المصدر: Market Watch
وكالة أنباء
عام
أهمية متوسطة
Lilly's revenue soars 48%, driven by demand of its GLP-1s
Its sales were driven by higher-than-expected demand for Mounjaro and Zepbound, its GLP-1 drugs for Type 2 diabetes and weight loss.
المصدر: Market Watch
زيارة المصدر